| Literature DB >> 25170290 |
Young-Han Park1, Seong Cheon Yang2, Sung Taek Park3, Sung Ho Park3, Hong Bae Kim3.
Abstract
BACKGROUND: Our purpose was to provide the clinical advantages of the laparoscopic approach compare to the vaginal approach in correcting uterine and vaginal vault prolapse.Entities:
Keywords: laparoscopy.; pelvic reconstructive surgery; uterine vaginal vault prolapse
Mesh:
Year: 2014 PMID: 25170290 PMCID: PMC4147633 DOI: 10.7150/ijms.9027
Source DB: PubMed Journal: Int J Med Sci ISSN: 1449-1907 Impact factor: 3.738
Demographic characteristics.
| Vaginal (n =120 ) | Lsc. (n=54) | p-value | |
|---|---|---|---|
| Age ,yrs(mean ± SD) | 64.4 ± 8.2 | 66.9 ± 9.6 | 0.096 |
| Parity(mean ± SD) | 3.5 ± 1.5 | 3.5 ± 1.8 | 0.986 |
| BMI, Kg/m3(mean ± SD) | 24.5 ± 3.1 | 24.8 ± 3.2 | 0.620 |
| Prior pelvic surgery, n(%) | 34 (28.3 %) | 16 (29.6%) | 0.861 |
| 2 | 43 (35.8%) | 12 (22.2%) | 0.188 |
| 3 | 62 (51.7%) | 35 (64.8%) | |
| 4 | 15 (12.5%) | 7 (13.0%) | |
| Uterine prolapsed grade (mean ± SD) | 2.8 ± 0.7 | 2.9 ± 0.6 | 0.180 |
| Uterine/vault prolapse | 120 (100.0%) | 54 (100.0%) | NA |
| cystocele | 31 (25.8%) | 14 (25.9%) | 0.990 |
| rectocele | 25 (20.8%) | 17 (31.5%) | 0.129 |
| Hysterectomy | 114 (95.0%) | 41 (75.9%) | <0.001 a |
| Sacrocolpopexy | 0 (0.0%) | 54 (100.0%) | <0.001 a |
| Uterosacral suspension | 98 (81.7%) | 0 (0.0%) | <0.001 a |
| Anterior colporrhaphy | 114 (95.0%) | 27 (50.0%) | <0.001 a |
| Posterior colporrhaphy | 118 (98.3%) | 34 (63.0%) | <0.001 a |
| Anti-incontinence surgery | 1 (0.8 %) | 2 (3.7%) | 0.228 b |
| F/U duration, months(mean ± SD) | 31.3 ± 7.6 | 29.7 ± 9.7 | 0.251 |
Vaginal : vaginal approach, Lsc : laparoscopic approach; Baden-Walker classification, uterine prolapse grade according; POP: pelvic organ prolapse; NA, not applicable, a p < 0.05; b Fisher's exact test.
Clinical outcomes of two groups.
| Vaginal Approach (n =120 ) | Lsc approach (n=54) | p-value | |
|---|---|---|---|
| Hemoglobin change, gm/dL (mean ± SD) | 1.4± 0.9 | 1.5±0.9 | 0.924 |
| No. of women transfused, n(%) | 0 (0%) | 0 (0%) | NA |
| Catheter duration, day (mean ± SD) | 4.7± 1.9 | 3.4±2.1 | <0.001 a |
| Catheter duration >5 days , n(%) | 33 (27.5%) | 4 (7.4%) | 0.003 a |
| Febrile morbidity, n(%) | 4 (3.3%) | 4 (7.4%) | 0.256 b |
| Operation time , min (mean ± SD) | 108.2± 38.6 | 168.3± 69.7 | <0.001 a |
| Post-op. hospital stay, day (mean ± SD) | 6.4 ± 2.1 | 5.0 ±1.9 | <0.001 a |
| Estimated blood loss, ml (mean ± SD) | 285.6±130.7 | 315.8 ± 99.6 | 0.098 |
| Conversion to laparotomy, n(%) | 0 (0%) | 0(0%) | NA |
Lsc : laparoscopy; NA, not applicable, a p<0.05; b Fisher's exact test
Peri-operative symptom changes.
| pre-op | p-value | post-op | p-value | |||
|---|---|---|---|---|---|---|
| Vaginal (n =120 ) | Lsc. (n=54) | p-value | Vaginal (n =120 ) | Lsc. (n=54) | p-value | |
| VPS, n(%) | 118 (98.3%) | 52 (96.3%) | 0.589 a | 6 (5.0%) | 3 (5.6%) | 1.000 a |
| Urinary, n(%) | 43 (35.8%) | 13 (24.1%) | 0.125 | 6 (5.0%) | 2 (3.7%) | 1.000 a |
| GI, n(%) | 0 (0.0%) | 1 (1.9%) | 0.310 a | 0 (0.0%) | 0 (0.0%) | NA |
Vaginal: vaginal approach, Lsc: laparoscopic approach, pre-op: pre-operation, VPS: Vaginal-perineal symptom, post-op: post-operation, NA: not applicable, a Fisher's exact test.
Post-operative wound complications during follow-up showed no significant differences.
| Wound complication, n(%) | Vaginal approach (n =120 ) | Lsc approach (n=54) | p-value |
|---|---|---|---|
| Infection, | 3 (2.5%) | 0 (0.0%) | |
| Hematoma | 1 (0.8%) | 0 (0.0%) | |
| Disruption | 1 (0.8%) | 0 (0.0%) | |
| Mesh erosion | 0 (0.0%) | 3 (5.8%) | |
| Total | 5 (4.2%) | 3 (5.6%) | 0.705 a |
Lsc : laparoscopic; a Fisher's exact test.
Recurrence of pelvic organ prolapse during follow-up showed no significant difference.
| Part of recurrence n(%) | Recurrence | p-value | Requiring reoperation | p-value | ||
|---|---|---|---|---|---|---|
| Vaginal (n =120) | Lsc. (n=54) | p-value | Vaginal (n =120) | Lsc. (n=54) | p-value | |
| Cystocele | 4 (3.3%) | 0 (0.0%) | 3 (2.5%) | 0 (0.0%) | ||
| VVP | 4 (3.3%) | 0 (0.0%) | 4 (3.3%) | 0 (0.0%) | ||
| Rectocele | 3 (2.5%) | 0 (0.0%) | 3 (2.5%) | 0 (0.0%) | ||
| Total | 11 (9.2%) | 0 (0.0%) | 0.019 a | 10 (8.3%) | 0 (0.0%) | 0.032 a |
| Success rate: | 110 (91.7%) | 54 (100.0%) | P=0.032 a | |||
Vaginal: vaginal approach, Lsc: laparoscopic approach, VVP: Vaginal vault prolapsed, a Fisher's exact test.